HIV and Inflammatory or Autoimmune Disease: Rare Patients, Many Questions (MAIVIH)

NCT05036811 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-09-08

No results posted yet for this study

Summary

Follow-up registry of patients living with HIV who also have various inflammatory and autoimmune pathologies that may require immunosuppressive treatment.

Conditions

Interventions

OTHER

data collection

data collection

Sponsors & Collaborators

  • Tourcoing Hospital

    lead OTHER

Principal Investigators

  • Nathalie VIGET, MD · CH TOURCOING

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-07
Primary Completion
2022-12-31
Completion
2023-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05036811 on ClinicalTrials.gov